Table of contents

Ovarian Cancer

• Does the Diagnosis of Breast or Ovarian Cancer Trigger Referral to Genetic Counseling? (1 March, 2013)

  C. Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman
• The Prevalence of Human Papillomavirus in Ovarian Cancer: A Systematic Review (1 March, 2013)

  Maria Inês Rosa, Geraldo Doneda Silva, Priscyla Waleska Targino de Azedo Simões, Meriene Viquetti Souza, Ana Paula Ronzani Panatto, Carla Sasso Simon, Kristian Madeira, Lidia Rossi Medeiros
• Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? (1 March, 2013)

  Roberto Angioli, Francesco Plotti, Alessia Aloisi, Stella Capriglione, Corrado Terranova, Roberto Ricciardi, Roberto Montera, Marzio Angelo Zullo, Virginia Rasi, Pierluigi Benedetti-Panici
• HSP60 Predicts Survival in Advanced Serous Ovarian Cancer (1 March, 2013)

  Elisabet Hjerpe, Suzanne Egyhazi, Joseph Carlson, Marianne Frostvik Stolt, Kjell Schedvins, Hemming Johansson, Maria Shoshan, Elisabeth Åvall-Lundqvist
• A Detailed Study of Patients and Tumor Characteristics of Epithelial Ovarian Cancer in Saudi Women (1 March, 2013)

  Ismail A. Al-Badawi, Adnan R. Munkarah, Asmaa Tulbah, Inas I. Babic, Hamed Al Husaini, Sarfraz Ahmad
• Prognostic Factors and Clinical Outcome of Patients With Recurrent Early-Stage Epithelial Ovarian Cancer: An Italian Multicenter Retrospective Study (1 March, 2013)

  Angiolo Gadducci, Stefania Cosio, Paolo Zola, Benedetta Sostegni, Luca Fuso, Enrico Sartori
• Characterization of Ovarian Tumors and Staging Ovarian Cancer With 3-Dimensional Power Doppler Angiography: Correlation With Pathologic Findings (1 March, 2013)

  Konstantinos Kalmantis, Alexandros Rodolakis, George Daskalakis, Aris Antsaklis
• Weekly Topotecan for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Tolerability and Efficacy Study—The Israeli Experience (1 March, 2013)

  Tamar Safra, Tara Berman, Adelya Yachnin, Ilan Bruchim, Mihai Meirovitz, Frida Barak, Ilan Atlas, Tally Levy, Ora Solange Rosengarten
• Feasibility of Trials in Ovarian Cancer by Line of Therapy and Platinum Sensitivity (1 March, 2013)

  Roekshana Shaboodien, Nikolaos Diamantis, Sarah Blagden, Hani Gabra, Roshan Agarwal